By Willemien Bax Data protection and consumer organisations.
Development of Pediatric ARV Drugs – FDA Perspective Linda L. Lewis, M.D. Medical Officer Division of Antiviral Drug Products U.S. Food and Drug Administration.
Safety Evaluation According To UK Regulations Dr Richard Crowther Head, Space Engineering & Technology Division Rutherford Appleton Laboratory Oxfordshire,
Simulation Models as a Research Method Professor Alexander Settles.
GG313 Lecture 3 8/30/05 Identifying trends, error analysis Significant digits.
Development of Pediatric ARV Drugs – FDA Perspective
GG313 Lecture 3 8/30/05
